Home | Welcome to Contract Pharma   
Last Updated Wednesday, November 26 2014
Print

Breaking News

November 25, 2014
Gains 50-bed, early-stage human clinical testing facilities  Read More »
November 25, 2014
Number of executives reduced from seven to six  Read More »
November 25, 2014
To provide emergency unblinding procedures for trials   Read More »
November 24, 2014
Janssen licenses Transposagen genome editing technologies  Read More »
November 24, 2014
Safety review finds increased number in deaths in the rilotumumab treatment arm  Read More »
November 24, 2014
Aims to develop, manufacture, and distribute NewLink's rVSV-EBOV candidate  Read More »
November 24, 2014
Will evaluate immunotherapies Opdivo and FPA008 in six tumor types  Read More »
November 21, 2014
Increased production capacity to support maturing biologics pipeline  Read More »
November 21, 2014
Gains rights to promising ophthalmology compound  Read More »
November 21, 2014
Expands capacity for immunology and oncology pipelines  Read More »
November 20, 2014
Enrolls first patient in Phase III linaclotide trial  Read More »
November 20, 2014
Graff brings extensive drug discovery and development experience  Read More »
November 20, 2014
Lonza to manufacture anti-cancer drug at Nansha and Visp facilities  Read More »
November 20, 2014
Aims to better support customers in the region   Read More »
November 20, 2014
Incorporates multiple technologies aimed at greater speed and efficiency  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On